Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Medtronic (MDT) Progresses in SNM With Updated InterStim Label

Medtronic (MDT) expects this updated labeling with wider procedural options and shorter wait time to improve patient access to MRI exams and add more flexibility for MRI providers.

Nalak Das headshot

Protect Your Portfolio From Volatility With 5 Low-Beta Picks

At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank as these will be less volatile than the broader market. These are: ABT, CAT, CNA, GOLF and SAFM.

OPKO Health (OPK) Q4 Earnings and Revenues Beat Estimates

OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.

Sheraz Mian headshot

Top Analyst Reports for Abbott, SAP & Freeport-McMoRan

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), SAP SE (SAP), and Freeport-McMoRan (FCX).

Medtronic's (MDT) Midas Rex Drills Completes First U.S. Surgery

Medtronic's (MDT) recent surgeries reach a milestone in the transformation of spine surgery as a result of increased accuracy and minimally invasive technique.

Globus Medical (GMED) Q4 Earnings Beat, U.S. Business Strong

Globus Medical's (GMED) spinal implant business performance varies by region in Q4.

Ecolab's (ECL) Certified Program to Build Customer Confidence

Ecolab's (ECL) science-backed comprehensive program to help food retailers to support customer confidence.

Masimo (MASI) Announces Full Market RollOut of SafetyNet-OPEN

Masimo (MASI) SafetyNet-OPEN aids organizations in detecting those who are most vulnerable to COVID-19.

Illumina (ILMN) Sequencing & Microarray Sales Hurt by Pandemic

Seasonality in DTC functionality also continues to erode Illumina's (ILMN) microarray sales.

Henry Schein (HSIC) Q4 Earnings Top Estimates, Margins Dip

Henry Schein (HSIC) sees robust segmental performance in Q4 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.

Bruker (BRKR) Q4 Earnings Surpass Estimates, Margins Rise

Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.

Exact Sciences (EXAS) Q4 Earnings, Revenues Top Estimates

Exact Sciences' (EXAS) legacy Screening business sees an uptick in revenues in Q4 earnings.

Here's Why You Should Hold on to McKesson (MCK) Stock Now

McKesson (MCK) continues to benefit from the multi-year strategic growth initiative and strength in the Distribution Solutions segment.

Zacks.com featured highlights include: Abbott Laboratories, Facebook, Stanley Black & Decker, Leidos and Euronet

Zacks.com featured highlights include: Abbott Laboratories, Facebook, Stanley Black & Decker, Leidos and Euronet

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

Ecolab (ECL) Q4 Earnings In Line With Estimates, Revenues Lag

Although Ecolab's (ECL) fourth-quarter results reflect weakness in the Global Industrial and Institutional segments, its Global Healthcare and Life Sciences unit shows strength.

CVS Health (CVS) Q4 Earnings Top Estimates but Decline Y/Y

The pandemic affects CVS Health's (CVS) fourth-quarter revenues in the Pharmacy Services segments as new therapy prescriptions reduce due to lower provider visits.

BD (BDX) Gets EUA, CE Mark for New Molecular Diagnostic Test

BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.

Swayta Shah headshot

5 Top Ranked Stocks With Solid Sales Growth to Buy Right Now

Sales growth is an important indicator of a company's health and ability to sustain its business. Let's check Abbott (ABT), Facebook (FB), Stanley Black & Decker (SWK), Leidos (LDOS) & Euronet (EEFT) as these might witness solid sales growth.

TeleFlex (TFX) Organic Sales Hit by COVID-19, Urolift Grows

TeleFlex (TFX) Interventional business revenues are down due to the cancellation of certain non-emergent procedures.

Intersect ENT's (XENT) SDS With PROPEL Mini Now in U.S.

Intersect ENT's (XENT) SDS, packaged with its PROPEL Mini Sinus Implant, is expected to boost the company's business following its U.S. availability.

DaVita (DVA) Q4 Earnings and Revenues Fall Shy of Estimates

DaVita's (DVA) bottomline in Q4 declines year over year.

DexCom (DXCM) Q4 Earnings Match Estimates, Revenues Beat

DexCom's (DXCM) fourth-quarter results benefit from domestic and international revenue growth.

Zimmer (ZBH) Non-Core Arm Spinoff to Aid Amid COVID-19 Crisis

In the Americas, there is increased pressure on Zimmer Biomet (ZBH) procedural volume as a result of surge in infections.

Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise

Bio-Rad's (BIO) fourth-quarter 2020 results reflect strong performance by the Life Science segment, boosted by coronavirus-led increased testing demand.